These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29485883)

  • 1. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26.
    Thom G; Burrell M; Haqqani AS; Yogi A; Lessard E; Brunette E; Delaney C; Baumann E; Callaghan D; Rodrigo N; Webster CI; Stanimirovic DB
    Mol Pharm; 2018 Apr; 15(4):1420-1431. PubMed ID: 29485883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
    Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
    J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis.
    Chang HY; Wu S; Li Y; Zhang W; Burrell M; Webster CI; Shah DK
    MAbs; 2021; 13(1):1874121. PubMed ID: 33499723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants.
    Bien-Ly N; Yu YJ; Bumbaca D; Elstrott J; Boswell CA; Zhang Y; Luk W; Lu Y; Dennis MS; Weimer RM; Chung I; Watts RJ
    J Exp Med; 2014 Feb; 211(2):233-44. PubMed ID: 24470444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.
    Moos T; Morgan EH
    J Neurochem; 2001 Oct; 79(1):119-29. PubMed ID: 11595764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and brain uptake of lactoferrin in rats.
    Ji B; Maeda J; Higuchi M; Inoue K; Akita H; Harashima H; Suhara T
    Life Sci; 2006 Jan; 78(8):851-5. PubMed ID: 16165165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.
    Yu YJ; Zhang Y; Kenrick M; Hoyte K; Luk W; Lu Y; Atwal J; Elliott JM; Prabhu S; Watts RJ; Dennis MS
    Sci Transl Med; 2011 May; 3(84):84ra44. PubMed ID: 21613623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of distorted iron regulation in the blood-CSF barrier and regional blood-brain barrier following in vivo subchronic manganese exposure.
    Li GJ; Choi BS; Wang X; Liu J; Waalkes MP; Zheng W
    Neurotoxicology; 2006 Sep; 27(5):737-44. PubMed ID: 16545456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor.
    Pardridge WM; Boado RJ; Patrick DJ; Ka-Wai Hui E; Lu JZ
    Mol Pharm; 2018 Nov; 15(11):5207-5216. PubMed ID: 30226787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody.
    Wu D; Pardridge WM
    Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
    Clark AJ; Davis ME
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.
    Niewoehner J; Bohrmann B; Collin L; Urich E; Sade H; Maier P; Rueger P; Stracke JO; Lau W; Tissot AC; Loetscher H; Ghosh A; Freskgård PO
    Neuron; 2014 Jan; 81(1):49-60. PubMed ID: 24411731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.